Healthcare Equity
Fundamental, science-driven equity strategy focused on providing exposure to specific disease indications through investments in biopharma companies
StemPoint Capital (“StemPoint”) is a biopharma focused equity strategy. StemPoint seeks to employ a fundamental, science-driven research process focused on providing exposure to sector themes and specific disease indications through investments in large-cap biopharmaceutical companies and small/mid-cap biotechnology companies.